Purified anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_Purified_041106
C57BL/6 mouse splenocytes were stained with purified CD8 (clone 53-6.7) (filled histogram) or rat IgG2a, κ isotype control (open histogram), followed by anti-rat IgG FITC.
  • 53-6dot7_Purified_041106
    C57BL/6 mouse splenocytes were stained with purified CD8 (clone 53-6.7) (filled histogram) or rat IgG2a, κ isotype control (open histogram), followed by anti-rat IgG FITC.
  • 53-6dot7_Purified_IHC_011917
    C57BL/6 frozen mouse spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD8a (clone 53-6.7), 10 µg/mL of Alexa Fluor® 647 anti-CD20 (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 anti-rat IgG2a (clone MRG2a-83) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 53-6dot7_Purified_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD8a clone 53-6.7 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Cat # Size Price Quantity Check Availability Save
100701 50 µg 24,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100702 500 µg 72,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF®, IHC-F - Verified
IP - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. For immunohistochemistry on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, and immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
Product Citations
  1. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  2. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  3. Mori H, et al. 2015. Toxicol Pathol. 43: 883-889. PubMed
  4. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  5. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  6. Zhang Z, et al. 2020. Front Immunol. 1.844444444. PubMed
  7. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  8. Sami E, et al. 2020. Cancer Res. 80:1102. PubMed
  9. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  10. Furukawa K,et al. 2017. PLoS One. 10.1371/journal.pone.0184901. PubMed
  11. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  12. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  13. Pittala S, et al. 2018. Neoplasia. 9:20222. PubMed
  14. Rubio‐Patiño C et al. 2018. Cell metabolism. 27(4):828-842 . PubMed
  15. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  16. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  17. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  18. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  19. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  20. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  21. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  22. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  23. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  24. Goel S, et al. 2017. Nature. 548:471. PubMed
  25. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  26. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  27. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  28. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  29. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  30. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  31. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  32. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  33. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  34. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  35. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  36. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  37. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  38. Lee YJ, et al. 2018. FASEB J. 32:4658. PubMed
  39. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  40. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  41. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  42. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  43. Bartsch YC, et al. 2018. Front Immunol. 1.196527778. PubMed
  44. Hiratsuka S, et al. 2018. EMBO Mol Med. 10:e8643. PubMed
  45. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  46. Zhao F, et al. 2018. Cancer Immunol Res. 1.263194444. PubMed
  47. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  48. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  49. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  50. Kaplanov I, et al. 2019. Proc Natl Acad Sci U S A. 116:1361. PubMed
  51. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  52. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  53. Tan CL, et al. 2018. Immunohorizons. 0.248611111. PubMed
  54. Atif SM, et al. 2019. JCI Insight. 4:e125494. PubMed
  55. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  56. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  57. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  58. Chen YQ, et al. 2019. J Immunother Cancer. 0.415277778. PubMed
  59. Asthagiri Arunkumar G, et al. 2019. Vaccine. 37:5567. PubMed
  60. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  61. Sutherland APR, et al. 2019. Sci Rep. 9:15302. PubMed
  62. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  63. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  64. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  65. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  66. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  67. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  68. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  69. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  70. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  71. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  72. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  73. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  74. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  75. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  76. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  77. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  78. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  79. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  80. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  81. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  82. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  83. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  84. Sharba S, et al. 2019. Virulence. 10:97. PubMed
  85. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  86. Chihara N, et al. 2018. Nature. 558:454. PubMed
  87. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  88. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  89. Kakaradov B, et al. 2017. Nat Immunol. 18:422. PubMed
  90. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  91. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  92. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  93. Majer O, et al. 2019. Nature. 575:366. PubMed
  94. Brown ZJ, et al. 2018. Cell Death Dis. 0.805555556. PubMed
  95. Lee B, et al. 2019. Front Immunol. 0.561805556. PubMed
  96. Kao C, et al. 2005. Int Immunol. 1.824305556. PubMed
  97. Ko S, et al. 2005. J Immunol. 175:3309. PubMed
  98. Genton C, et al. 2006. J Immunol. 177:2285. PubMed
  99. Guo Y, et al. 2008. Blood. 112:480. PubMed
  100. Jordan J, et al. 2008. Infect Immun. 76:3717. PubMed
  101. Kenna T, et al. 2008. Blood. 111:2091. PubMed
RRID
AB_312740 (BioLegend Cat. No. 100701)
AB_312741 (BioLegend Cat. No. 100702)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC, IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC, 3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC, IHC-F, 3D IHC
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC, IHC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC, CyTOF®, IHC, IP, Depletion, Block
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F, FC, 3D IHC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC, CyTOF®
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Go To Top Version: 5    Revision Date: 12.03.2020

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD8a

  • Biotin anti-mouse CD8a

  • FITC anti-mouse CD8a

  • PE anti-mouse CD8a

  • PE/Cyanine5 anti-mouse CD8a

  • APC/Cyanine7 anti-mouse CD8a

  • Alexa Fluor® 488 anti-mouse CD8a

  • Alexa Fluor® 647 anti-mouse CD8a

  • Pacific Blue™ anti-mouse CD8a

  • Brilliant Violet 421™ anti-mouse CD8a

  • Ultra-LEAF™ Purified anti-mouse CD8a

  • Alexa Fluor® 594 anti-mouse CD8a

  • GoInVivo™ Purified anti-mouse CD8a

  • PE/Cyanine7 anti-mouse CD8a

  • Alexa Fluor® 700 anti-mouse CD8a

  • Brilliant Violet 785™ anti-mouse CD8a

  • PE/Fire™ 640 anti-mouse CD8a

  • Spark Blue™ 550 anti-mouse CD8a

  • Spark NIR™ 685 anti-mouse CD8a

  • TotalSeq™-C0002 anti-mouse CD8a

  • Brilliant Violet 570™ anti-mouse CD8a

  • Brilliant Violet 510™ anti-mouse CD8a

  • Purified anti-mouse CD8a (Maxpar® Ready)

  • TotalSeq™-A0002 anti-mouse CD8a

  • PE/Fire™ 700 anti-mouse CD8a

  • PerCP/Cyanine5.5 anti-mouse CD8a

  • PerCP anti-mouse CD8a

  • Brilliant Violet 711™ anti-mouse CD8a

  • TotalSeq™-B0002 anti-mouse CD8a

  • Spark YG™ 570 anti-mouse CD8a

  • APC/Fire™ 750 anti-mouse CD8a

  • Brilliant Violet 650™ anti-mouse CD8a

  • Brilliant Violet 605™ anti-mouse CD8a

  • PE/Dazzle™ 594 anti-mouse CD8a

  • Spark Violet™ 423 anti-mouse CD8a Antibody

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account